Should Midazolam Drug-Drug Interactions be of Concern to Palliative Care Physicians?

被引：5
|
作者：
Kotlinska-Lemieszek, Aleksandra [1 ]
机构：
[1] Poznan Univ Med Sci, Palliat Med Chair & Dept, Poznan, Poland
来源：
DRUG SAFETY | 2013年 / 36卷 / 09期
关键词：
ORAL MIDAZOLAM; ITRACONAZOLE; KETOCONAZOLE; FLUCONAZOLE; CYP3A;
D O I：
10.1007/s40264-013-0066-2
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：789 / 790
页数：2
相关论文
共 50 条
  • [1] Should Midazolam Drug–Drug Interactions be of Concern to Palliative Care Physicians?
    Aleksandra Kotlinska-Lemieszek
    Drug Safety, 2013, 36 : 789 - 790
  • [2] Author's Reply to Kotlinska-Lemieszek: "Should Midazolam Drug-Drug Interactions Be of Concern to Palliative Care Physicians?"
    Frechen, Sebastian
    Gaertner, Jan
    DRUG SAFETY, 2013, 36 (09) : 791 - 792
  • [3] Author’s Reply to Kotlinska-Lemieszek: “Should Midazolam Drug–Drug Interactions Be of Concern to Palliative Care Physicians?”
    Sebastian Frechen
    Jan Gaertner
    Drug Safety, 2013, 36 : 791 - 792
  • [4] Drug-drug interactions you should know!
    Voigt, Niels
    Ort, Katharina
    Sossalla, Samuel
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (04) : 264 - 275
  • [5] Drug-drug interactions: How scared should we be?
    Shapiro, LE
    Shear, NH
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1999, 161 (10) : 1266 - 1267
  • [6] Effect of Continuity of Care on Drug-Drug Interactions
    Guo, Jiun-Yu
    Chou, Yiing-Jenq
    Pu, Christy
    MEDICAL CARE, 2017, 55 (08) : 744 - 751
  • [7] SUBLIMINAL DRUG-DRUG INTERACTIONS - USERS AND THEIR PHYSICIANS TAKE NOTICE
    SCHENKER, S
    MADDREY, WC
    HEPATOLOGY, 1991, 13 (05) : 995 - 998
  • [8] Surveillance of Physicians Causing Potential Drug-Drug Interactions in Ambulatory Care: A Pilot Study in Switzerland
    Bucher, Heiner C.
    Achermann, Rita
    Stohler, Nadja
    Meier, Christoph R.
    PLOS ONE, 2016, 11 (01):
  • [9] Drug interactions in palliative care
    Bernard, SA
    Bruera, E
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) : 1780 - 1799
  • [10] Clinically Relevant Drug-Drug Interactions in Primary Care
    Carpenter, Mary
    Berry, Holly
    Pelletier, Allen L.
    AMERICAN FAMILY PHYSICIAN, 2019, 99 (09) : 558 - 564
12345